- Home
- CRNX vs BGC Comparison
CRNX vs BGC Comparison
Compare CRNX & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNX | BGC |
|---|---|---|
| Founded | 2008 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.4B |
| IPO Year | 2018 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CRNX | BGC |
|---|---|---|
| Price | $55.90 | $8.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $73.70 | $14.50 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.88% |
| EPS Growth | N/A | ★ 36.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | $1,535,000.00 | ★ $2,640,884,000.00 |
| Revenue This Year | $425.41 | $36.34 |
| Revenue Next Year | $943.30 | $11.45 |
| P/E Ratio | ★ N/A | $27.38 |
| Revenue Growth | ★ 47.74 | 24.59 |
| 52 Week Low | $24.10 | $7.24 |
| 52 Week High | $57.99 | $10.96 |
Technical Indicators
Market Signals| Indicator | CRNX | BGC |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 54.68 |
| Support Level | $53.45 | $8.59 |
| Resistance Level | $56.23 | $8.89 |
| Average True Range (ATR) | 3.09 | 0.20 |
| MACD | 0.60 | -0.00 |
| Stochastic Oscillator | 84.22 | 66.67 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About BGC BGC Group Inc.
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.